接受长期抗凝治疗患者使用糖蛋白抑制剂：足够安全还是风险过高？ - Suppr | 超能文献

Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?

作者信息

Marín Francisco, Bonacasa Bárbara, Valdés Mariano

出版信息

Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1.

DOI:10.1160/TH09-10-0694

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?接受长期抗凝治疗患者使用糖蛋白抑制剂：足够安全还是风险过高？

Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1.

2

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.急性冠状动脉综合征和/或经皮冠状动脉介入治疗/支架置入术的心房颤动患者的抗栓治疗管理。

Thromb Haemost. 2010 Jan;103(1):13-28. doi: 10.1160/TH09-08-0580. Epub 2009 Sep 30.

3

Oral antiplatelet therapy in PCI patients.经皮冠状动脉介入治疗（PCI）患者的抗血小板治疗。

Catheter Cardiovasc Interv. 2010 Mar 1;75 Suppl 1:S7-14. doi: 10.1002/ccd.22367.

4

Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.口服抗凝治疗患者行经皮冠状动脉介入治疗的抗栓策略：基于个体风险分层的建议算法。

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):128-34. doi: 10.1002/ccd.22200.

5

Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors.

J Invasive Cardiol. 2006 Jun;18(6):254-61.

6

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.药物洞察：有抗凝指征的经皮冠状动脉介入治疗患者的抗栓治疗

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. doi: 10.1038/ncpcardio0712.

7

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.心房颤动伴急性或慢性冠状动脉疾病的口服抗血栓治疗。

Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.

8

Hazard--the anticoagulation bridge or just go transradial.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):48-9. doi: 10.1002/ccd.21908.

9

Challenges of antiplatelet therapy in patients who require anticoagulation.需要抗凝治疗的患者抗血小板治疗面临的挑战。

J Invasive Cardiol. 2009 Apr;21(4):186-9.

10

Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):416-7. doi: 10.1002/ccd.22218.